MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients

Overview of attention for article published in Frontiers in oncology, October 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 25,509 followers.

RT @FrontOncology: New research: MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colore…

18 Nov 2022

Reply Repost Favourite

MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients https://t.co/OzBkXG14Jk

03 Nov 2022

Reply Repost Favourite

New article: MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients https://t.co/DU7uUDjLox #colorectalcancer #oncology https://t.co/syd7Agoelz

03 Nov 2022

Reply Repost Favourite

#4 Original Research Article: MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in #colorectalcancer patients 👨‍⚕️👩‍⚕️ Horak J et al 👉 https://t.co/p8p9Fn6eMk #CancerTreatment #ncRNA

21 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.